1. Exosomal microRNAs in hepatocellular carcinoma
    Chenbin Liu et al, 2021, Cancer Cell International CrossRef
  2. Nucleoside hydrogel-modified cell subtype biosensor with antifouling and electroconductive properties
    Xinying Zhang et al, 2025, Talanta CrossRef
  3. MicroRNA dysregulation interplay with childhood abdominal tumors
    Karina Bezerra Salomão et al, 2019, Cancer and Metastasis Reviews CrossRef

  4. Exosomal MicroRNAs as Liquid Biopsy Biomarkers in Hepatocellular Carcinoma


    Shuo Wang et al, 2020, OncoTargets and Therapy CrossRef
  5. Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals
    Seung Wan Son et al, 2020, Molecules CrossRef
  6. Role of Extracellular Vesicles in Liver Diseases
    Viola Tamasi et al, 2023, Life CrossRef
  7. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway
    Yun Jin et al, 2017, Experimental Cell Research CrossRef
  8. miRNA in tumour metabolism and why could it be the preferred pathway for energy reprograming
    Aliaa A Alamoudi et al, 2018, Briefings in Functional Genomics CrossRef
  9. miR-10b-5p promotes tumor growth by regulating cell metabolism in liver cancer via targeting SLC38A2
    Mingzhi Xia et al, 2024, Cancer Biology & Therapy CrossRef
  10. Prognostic significance of miR-122 expression after curative resection in patients with hepatocellular carcinoma
    Sang Yun Ha et al, 2019, Scientific Reports CrossRef
  11. Targeting Hepatic Cancer Stem Cells (CSCs) and Related Drug Resistance by Small Interfering RNA (siRNA)
    Saade Abdalkareem Jasim et al, 2024, Cell Biochemistry and Biophysics CrossRef
  12. Specific tumor-derived CCL2 mediated by pyruvate kinase M2 in colorectal cancer cells contributes to macrophage recruitment in tumor microenvironment
    Kejian Zou et al, 2017, Tumor Biology CrossRef
  13. Retraction statement: microRNA‐497 inhibits cell proliferation and induces apoptosis by targeting YAP1 in human hepatocellular carcinoma
    , 2022, FEBS Open Bio CrossRef
  14. MicroRNA regulation and analytical methods in cancer cell metabolism
    Ling-Fei Zhang et al, 2017, Cellular and Molecular Life Sciences CrossRef
  15. Roles of Thyroid Hormone-Associated microRNAs Affecting Oxidative Stress in Human Hepatocellular Carcinoma
    Po-Shuan Huang et al, 2019, International Journal of Molecular Sciences CrossRef
  16. The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs
    Dexter L. Puckett et al, 2021, International Journal of Molecular Sciences CrossRef
  17. MicroRNA-122 mimic/microRNA-221 inhibitor combination as a novel therapeutic tool against hepatocellular carcinoma
    Marwa Hassan et al, 2023, Non-coding RNA Research CrossRef
  18. Hepatocellular carcinoma in patients with HIV
    Imane El Dika et al, 2017, Current Opinion in HIV and AIDS CrossRef
  19. Exosomal miR-155 Derived from Hepatocellular Carcinoma Cells Under Hypoxia Promotes Angiogenesis in Endothelial Cells
    Yusuke Matsuura et al, 2019, Digestive Diseases and Sciences CrossRef
  20. Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison
    Sijia Shen et al, 2016, Scientific Reports CrossRef
  21. Effects of PKM2 on global metabolic changes and prognosis in hepatocellular carcinoma: from gene expression to drug discovery
    Wen-Wen Lv et al, 2018, BMC Cancer CrossRef
  22. Upregulated lncRNA-UCA1 contributes to metastasis of bile duct carcinoma through regulation of miR-122/CLIC1and activation of the ERK/MAPK signaling pathway
    Lei Kong et al, 2019, Cell Cycle CrossRef
  23. A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2
    Sahil Arora et al, 2022, Journal of Medicinal Chemistry CrossRef
  24. Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
    Kwang-Hoon Chun, 2022, Pharmaceutics CrossRef
  25. miRNA‑766 induces apoptosis of human colon cancer cells through the p53/Bax signaling pathway by MDM4
    Weirong Chen et al, 2019, Experimental and Therapeutic Medicine CrossRef
  26. Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis
    Yue Zhang et al, 2017, Oncotarget CrossRef
  27. Protective effect of Coptisine from Rhizoma Coptidis on LPS/D-GalN-induced acute liver failure in mice through up-regulating expression of miR-122
    Fang-Ni Chai et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  28. Accurate cancer cell identification and microRNA silencing induced therapy using tailored DNA tetrahedron nanostructures
    Juan Su et al, 2020, Chemical Science CrossRef
  29. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma
    Jiao Feng et al, 2020, Journal of Experimental & Clinical Cancer Research CrossRef
  30. Downregulation of miR-122-5p Activates Glycolysis via PKM2 in Kupffer Cells of Rat and Mouse Models of Non-Alcoholic Steatohepatitis
    Yosuke Inomata et al, 2022, International Journal of Molecular Sciences CrossRef
  31. miR-140-5p induces cell apoptosis and decreases Warburg effect in chronic myeloid leukemia by targeting SIX1
    Zi-Yuan Nie et al, 2019, Bioscience Reports CrossRef
  32. Dysregulated MicroRNA Fingerprints and Methylation Patterns in Hepatocellular Carcinoma, Cancer Stem Cells, and Mesenchymal Stem Cells
    Mohamed A. Nasr et al, 2019, Frontiers in Cell and Developmental Biology CrossRef
  33. RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?
    Kurt Sartorius et al, 2022, Frontiers in Oncology CrossRef
  34. Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA
    Mohammad S. Alzahrani et al, 2024, Cell Biochemistry and Biophysics CrossRef
  35. Circulating miR-122 and miR-200a as biomarkers for fatal liver disease in ART-treated, HIV-1-infected individuals
    Daniel D. Murray et al, 2017, Scientific Reports CrossRef
  36. BRCA1 overexpression attenuates breast cancer cell growth and migration by regulating the pyruvate kinase M2-mediated Warburg effect via the PI3K/AKT signaling pathway
    Xiuli Liu et al, 2022, PeerJ CrossRef
  37. Clinical value of miRNA‑122 in the diagnosis and prognosis of various types of cancer
    Meiyu Dai et al, 2019, Oncology Letters CrossRef
  38. The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma
    Wenwei Liao et al, 2022, International Journal of Cancer CrossRef
  39. The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma
    Yanfang Zhang et al, 2019, Medicine CrossRef
  40. Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis
    Qiuran Xu et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  41. Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets
    Jinghang Xu et al, 2020, Frontiers in Oncology CrossRef
  42. The mechanistic, diagnostic and therapeutic novel nucleic acids for hepatocellular carcinoma emerging in past score years
    Song Zhang et al, 2021, Briefings in Bioinformatics CrossRef
  43. Ultrasound-Assisted miR-122-Loaded Polymeric Nanodroplets for Hepatocellular Carcinoma Gene Therapy
    Huanling Guo et al, 2020, Molecular Pharmaceutics CrossRef
  44. miR‐98‐5p promotes apoptosis and inhibits migration and cell growth in papillary thyroid carcinoma through Bax/Caspase‐3 by HMGA2
    Kai Qiu et al, 2020, Journal of Clinical Laboratory Analysis CrossRef